Intermex Reports Earnings While Western Union Watches Its Cross-Border Payments Strategy Unfold
International Money Express Inc. (IMXI) reports second-quarter 2026 earnings on August 10, with analysts expecting $0.51 per share—a notable improvement from the prior quarter's disappointing $0.07 result that badly missed estimates. The central question is whether the remittance specialist can reverse its recent earnings volatility and restore investor confidence after two consecutive quarters of significant misses, particularly as the stock trades well below all major moving averages and technical indicators flash maximum sell signals.
Part 1: Earnings Preview
International Money Express operates as a money remittance services company, primarily facilitating cross-border transfers between the United States and Latin America through its network of retail locations and digital platforms. The company serves immigrant communities sending funds to their home countries, making it sensitive to both economic conditions and regulatory changes in key corridors.
IMXI is scheduled to report Q2 2026 earnings on August 10, with the consensus estimate calling for $0.51 per share on revenue of approximately $137.96 million. The most recently reported quarter (Q1 2026) delivered actual EPS of $0.07, representing a severe 80.56% miss against the $0.36 estimate. Year-over-year, the Q2 estimate of $0.51 represents a 10.87% increase from the $0.46 reported in Q2 2025, suggesting analysts expect a return to growth despite recent stumbles.
Three key themes define this earnings story:
1. Recovery from Q1's Operational Disruption: The dramatic Q1 miss raises questions about whether the company faced one-time headwinds or structural challenges. Investors will scrutinize management's explanation and look for evidence that Q2 represents a clean quarter with normalized operations.
2. Revenue Pressure in Core Corridors: Analyst estimates point to revenue of $137.96 million, down 14.38% year-over-year from $161.13 million in Q2 2025. This significant contraction suggests ongoing challenges in transaction volumes or pricing power in key remittance corridors, potentially driven by economic conditions in Latin America or increased competition.
3. Estimate Volatility and Credibility: The Q2 estimate has been revised dramatically—from $0.46 just 90 days ago to the current $0.51—while Q3 estimates have swung from $0.47 to $0.55. This unusual upward revision pattern following a massive miss suggests either improving business fundamentals or analyst recalibration, making guidance commentary critical.
Analyst commentary ahead of the release remains cautious, with all seven covering analysts maintaining Hold ratings and no buy or sell recommendations. The consensus price target of $16.00 implies approximately 31% upside from current levels, but the uniform neutral stance reflects uncertainty about the company's near-term trajectory following the Q1 disappointment.
Part 2: Historical Earnings Performance
IMXI's recent earnings history reveals a troubling pattern of estimate misses and significant volatility. Over the past four quarters, the company has delivered two substantial disappointments alongside two in-line or unavailable comparison periods.
The Q2 2025 result came in exactly at the $0.46 estimate, representing a rare moment of predictability. However, Q3 2025 saw the company report $0.32 against a $0.50 estimate—a 36.00% miss that marked the beginning of execution concerns. The Q4 2025 quarter reported $0.35, though no estimate was available for comparison. Most recently, Q1 2026 delivered the worst performance with $0.07 versus the $0.36 estimate—an 80.56% shortfall that shocked investors and raised serious questions about business fundamentals.
This pattern shows a company struggling with forecast accuracy and operational consistency. The severity of the recent misses, particularly the Q1 result that came in at less than 20% of expectations, suggests either significant business headwinds or a disconnect between management guidance and analyst models. The upcoming Q2 report will be critical in determining whether Q1 represented an anomaly or the start of a more sustained downturn.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.46 | $0.46 | unch | Beat |
| Sep 2025 | $0.50 | $0.32 | -36.00% | Miss |
| Dec 2025 | N/A | $0.35 | N/A | N/A |
| Mar 2026 | $0.36 | $0.07 | -80.56% | Miss |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
IMXI's earnings timing is not specified in the available data, though historical patterns suggest after-market-close reporting, meaning Day 0 captures anticipatory moves while Day +1 reflects the market's first full reaction to results.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-11 | -$0.06 (-0.38%) | $0.11 (0.69%) | +$0.04 (+0.25%) | $0.08 (0.47%) |
| 2026-03-06 | +$0.02 (+0.13%) | $0.06 (0.38%) | +$0.01 (+0.06%) | $0.06 (0.38%) |
| 2025-11-10 | +$0.03 (+0.20%) | $0.06 (0.40%) | -$0.05 (-0.33%) | $0.18 (1.19%) |
| 2025-08-11 | +$5.62 (+60.56%) | $0.38 (4.09%) | -$0.14 (-0.94%) | $0.52 (3.48%) |
| 2025-05-07 | -$1.93 (-15.58%) | $1.94 (15.66%) | +$0.39 (+3.73%) | $0.50 (4.78%) |
| 2025-02-26 | -$3.06 (-16.70%) | $0.96 (5.24%) | +$0.67 (+4.39%) | $0.89 (5.83%) |
| 2024-11-08 | +$2.20 (+11.89%) | $1.26 (6.84%) | +$0.90 (+4.35%) | $0.96 (4.66%) |
| 2024-08-07 | -$4.42 (-20.16%) | $2.93 (13.37%) | -$0.10 (-0.57%) | $0.91 (5.20%) |
| Avg Abs Move | 15.70% | 5.83% | 1.83% | 3.25% |
Historical price behavior around IMXI earnings reveals extreme volatility with an average absolute Day 0 move of 15.70%—far above typical market reactions. The most dramatic examples include a 60.56% surge in August 2025 and declines of 20.16% (August 2024), 16.70% (February 2025), and 15.58% (May 2025). More recent quarters have shown moderation, with the three most recent reports producing Day 0 moves under 0.40%, suggesting either reduced volatility or different market conditions.
The average Day 0 range of 5.83% indicates substantial intraday swings regardless of direction, while the Day +1 average move of 1.83% shows continued volatility into the following session. Notably, several quarters exhibited significant follow-through action, including a 4.39% Day +1 gain following the February 2025 report and a 4.35% advance after November 2024. Investors should prepare for potentially significant price movement, though recent quarters suggest the extreme swings of 2024-2025 may have subsided.
Part 3: What Analysts Are Saying
Analyst sentiment toward IMXI remains decidedly neutral, with all seven covering analysts maintaining Hold ratings—no strong buys, moderate buys, sells, or strong sells in the current consensus. This uniform positioning at the midpoint of the rating scale (3.00 average recommendation) reflects significant uncertainty about the company's near-term prospects following recent earnings disappointments.
The consensus price target of $16.00 (with high, mean, and low estimates all identical) implies approximately 31% upside from the current $12.19 price level. However, this potential gain must be weighed against the lack of conviction evident in the rating distribution—no analyst is willing to recommend buying the stock despite the apparent discount to fair value.
Sentiment has remained unchanged over the past month, with the Hold count moving from 8 to 7 analysts but the average recommendation staying at 3.00. This stability suggests analysts are waiting for clearer evidence of operational improvement before adjusting their stance. The absence of any bullish or bearish outliers indicates consensus that IMXI is a "show me" story requiring proof of execution before warranting stronger recommendations.
Part 4: Technical Picture
IMXI enters earnings in a technically deteriorating position, with the Barchart Technical Opinion showing a 100% Sell signal—maximum bearish strength that has intensified from 72% Sell a month ago. This represents the strongest possible negative reading and suggests technical momentum has turned decisively against the stock.
Timeframe Analysis:
- Short-term (100% Sell): Maximum sell signal indicates severe near-term downward pressure with no technical support
- Medium-term (100% Sell): Equally bearish intermediate-term reading confirms the weakness extends beyond just short-term noise
- Long-term (100% Sell): Maximum long-term sell signal suggests the deterioration reflects fundamental trend breakdown rather than temporary volatility
Trend Characteristics: The combination of Maximum strength and Strongest direction indicates IMXI is in a powerful downtrend across all timeframes, creating a highly challenging technical environment heading into the earnings release.
The stock trades below all major moving averages, including the 5-day ($12.24), 10-day ($12.51), 20-day ($12.99), 50-day ($13.96), 100-day ($14.85), and 200-day ($15.11). This complete breakdown below key technical levels confirms the bearish signal structure.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $12.24 | 50-Day MA | $13.96 |
| 10-Day MA | $12.51 | 100-Day MA | $14.85 |
| 20-Day MA | $12.99 | 200-Day MA | $15.11 |
The widening gap between current price and moving averages—with the stock now 19.3% below its 200-day average—illustrates the severity of the technical damage. The uniform sell signals across all timeframes suggest any earnings-driven rally would face significant overhead resistance at each moving average level. From a technical perspective, IMXI needs not just a strong earnings beat but a fundamental catalyst capable of reversing deeply entrenched negative momentum. The setup is decidedly cautionary, with the stock lacking any technical support structure heading into what promises to be a high-stakes report.